^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Panretin (alitretinoin topical)

i
Other names: ALRT 1057, LG1057, LG-1057, LG 1057, 9-cis retinoic acid, 9-CRA
Associations
Trials
Company:
Eisai
Drug class:
Retinoid X receptor agonist
Associations
Trials
over1year
Kaposi Sarcoma Associated with Tofacitinib Use in a Patient with Rheumatoid Arthritis. (PubMed, R I Med J (2013))
The purple-red Kaposi sarcoma nodules decreased 50% in size after 4 months and resolved at 1 year off the tofacitinib and initiation of alitretinoin gel. As the use of immunomodulators and biologics continues to expand, awareness of this association is important for prompt diagnosis and management.
Journal
|
tofacitinib • Panretin (alitretinoin topical)